论文部分内容阅读
目的观察布地奈德雾化混悬液吸入治疗小儿急性喉炎的疗效。方法将63例急性喉炎患者随机分成布地奈德混悬液经空气压缩泵雾化吸入治疗组(30例)及静脉滴注地塞米松对照组(33例),两组间患儿年龄、性别、病程、临床表现、病例数差异无统计学意义(P>0.05),对两组患儿经不同治疗方法治疗后的临床表现及效果进行观察。结果结果显示在吸气喉鸣消失、犬吠样咳嗽消失、声嘶消失时间等方面治疗组与对照组比较P<0.001、P<0.01、P<0.05,差异有非常显著性意义。结论布地奈德雾化混悬液经空气压缩泵雾化吸入治疗对小儿急性喉炎疗效优于静脉注射地塞米松,且副作用小,适合在门诊应用。
Objective To observe the curative effect of budesonide inhalation in treating acute laryngitis in children. Methods A total of 63 patients with acute laryngitis were randomly divided into budesonide suspension inhalation group (n = 30) and intravenous dexamethasone control group (n = 33). The age, There was no significant difference in gender, course of disease, clinical manifestations, and number of cases (P> 0.05). The clinical manifestations and effects of the two groups of children treated by different treatments were observed. The results showed that there was significant difference between the treatment group and the control group (P <0.001, P <0.01, P <0.05) in the disappearance of suction throat, disappearance of bark-like cough and disappearance of hoarseness. Conclusion Budesonide aerosol suspension inhalation by air compression pump inhalation treatment of acute laryngitis in children is superior to dexamethasone intravenous injection, and the side effects of small, suitable for outpatient applications.